The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Chai-Adisaksopha C, Crowther M, Isayama T, Lim W. Rivaroxaban with or without aspirin in stable cardiovascular disease. Eikelboom JW, Connolly SJ, Bosch J et al. Apixaban versus warfarin in patients with atrial fibrillation. ![]() Granger CB, Alexander JH, McMurray JJ et al. Oral rivaroxaban for symptomatic venous thromboembolism. Investigators E, Bauersachs R, Berkowitz SD et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. ![]() Papers of special note have been highlighted as:
0 Comments
So what do our partnerships affect? Very little. Our partnerships exist to support our efforts to help our readers with free content. ![]() These partnerships never influence our reviews, rankings, or recommendations. We work with partners and may receive compensation through these partnerships. Nobody other than our editorial staff or advisory team have any influence over our reviews, rankings, or recommendations. When you read our reviews or check our top picks for cord-cutting products and services, you can trust that you're seeing the result of hours of testing and years of experience in the cord-cutting space. We make editorial decisions based on our expertise, first-hand experience, and informed opinions. We research options, new technology, share tips, review services, and more, at no cost to our readers. Our goal at is to help people save money on the TV they love and access it on-the-go. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |